 LA JOLLA, Calif.--BUSINESS WIRE--DermTech, Inc. NASDAQ: DMTK DermTech, a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that it plans to release its fourth quarter and full-year 2021 financial results after the market closes on Tuesday, March 1, 2022. In conjunction with such release, the Company plans to host a conference call and webcast that day at 1:30 p.m. Pacific time 4:30 p.m. Eastern time to discuss its financial results and r 